Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Candida auris, an emerging and disturbing yeast.

Coste AT, Imbert C, Hennequin C.

J Mycol Med. 2019 Jun;29(2):105-106. doi: 10.1016/j.mycmed.2019.05.002. No abstract available.

PMID:
31178041
2.

Investigating Antifungal Susceptibility in Candida Species With MALDI-TOF MS-Based Assays.

Delavy M, Dos Santos AR, Heiman CM, Coste AT.

Front Cell Infect Microbiol. 2019 Feb 7;9:19. doi: 10.3389/fcimb.2019.00019. eCollection 2019. Review.

3.

Review of the impact of MALDI-TOF MS in public health and hospital hygiene, 2018.

Rodríguez-Sánchez B, Cercenado E, Coste AT, Greub G.

Euro Surveill. 2019 Jan;24(4). doi: 10.2807/1560-7917.ES.2019.24.4.1800193.

4.

Condition-specific series of metabolic sub-networks and its application for gene set enrichment analysis.

Tran VDT, Moretti S, Coste AT, Amorim-Vaz S, Sanglard D, Pagni M.

Bioinformatics. 2018 Nov 16. doi: 10.1093/bioinformatics/bty929. [Epub ahead of print]

PMID:
30445518
5.

Efficacy of Antifungal Monotherapies and Combinations against Aspergillus calidoustus.

Glampedakis E, Coste AT, Aruanno M, Bachmann D, Delarze E, Erard V, Lamoth F.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e01137-18. doi: 10.1128/AAC.01137-18. Print 2018 Dec.

6.

Azole resistance in a Candida albicans mutant lacking the ABC transporter CDR6/ROA1 depends on TOR signaling.

Khandelwal NK, Chauhan N, Sarkar P, Esquivel BD, Coccetti P, Singh A, Coste AT, Gupta M, Sanglard D, White TC, Chauvel M, d'Enfert C, Chattopadhyay A, Gaur NA, Mondal AK, Prasad R.

J Biol Chem. 2018 Jan 12;293(2):412-432. doi: 10.1074/jbc.M117.807032. Epub 2017 Nov 20.

7.

A standardized toolkit for genetic engineering of CTG clade yeasts.

Defosse TA, Courdavault V, Coste AT, Clastre M, de Bernonville TD, Godon C, Vandeputte P, Lanoue A, Touzé A, Linder T, Droby S, Rosa CA, Sanglard D, d'Enfert C, Bouchara JP, Giglioli-Guivarc'h N, Papon N.

J Microbiol Methods. 2018 Jan;144:152-156. doi: 10.1016/j.mimet.2017.11.015. Epub 2017 Nov 16.

PMID:
29155237
8.

Red-Shifted Firefly Luciferase Optimized for Candida albicans In vivo Bioluminescence Imaging.

Dorsaz S, Coste AT, Sanglard D.

Front Microbiol. 2017 Aug 3;8:1478. doi: 10.3389/fmicb.2017.01478. eCollection 2017.

9.

Azole Resistance in Aspergillus fumigatus: A Consequence of Antifungal Use in Agriculture?

Berger S, El Chazli Y, Babu AF, Coste AT.

Front Microbiol. 2017 Jun 7;8:1024. doi: 10.3389/fmicb.2017.01024. eCollection 2017. Review.

10.

Unexpected Transcripts in Tn7 orf19.2646 C. albicans Mutant Lead to Low Fungal Burden Phenotype In vivo.

Pierrehumbert A, Ischer F, Coste AT.

Front Microbiol. 2017 May 16;8:873. doi: 10.3389/fmicb.2017.00873. eCollection 2017.

11.

Pleiotropic effects of the vacuolar ABC transporter MLT1 of Candida albicans on cell function and virulence.

Khandelwal NK, Kaemmer P, Förster TM, Singh A, Coste AT, Andes DR, Hube B, Sanglard D, Chauhan N, Kaur R, d'Enfert C, Mondal AK, Prasad R.

Biochem J. 2016 Jun 1;473(11):1537-52. doi: 10.1042/BCJ20160024. Epub 2016 Mar 29.

12.

Identification of Aspergillus fumigatus multidrug transporter genes and their potential involvement in antifungal resistance.

Meneau I, Coste AT, Sanglard D.

Med Mycol. 2016 Aug 1;54(6):616-27. doi: 10.1093/mmy/myw005. Epub 2016 Mar 1.

PMID:
26933209
13.

Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.

Sanglard D, Coste AT.

Antimicrob Agents Chemother. 2015 Oct 19;60(1):229-38. doi: 10.1128/AAC.02157-15. Print 2016 Jan.

14.

RNA Enrichment Method for Quantitative Transcriptional Analysis of Pathogens In Vivo Applied to the Fungus Candida albicans.

Amorim-Vaz S, Tran Vdu T, Pradervand S, Pagni M, Coste AT, Sanglard D.

MBio. 2015 Sep 22;6(5):e00942-15. doi: 10.1128/mBio.00942-15.

15.

Adaptation of a Gaussia princeps Luciferase reporter system in Candida albicans for in vivo detection in the Galleria mellonella infection model.

Delarze E, Ischer F, Sanglard D, Coste AT.

Virulence. 2015;6(7):684-93. doi: 10.1080/21505594.2015.1081330.

16.

Examining the virulence of Candida albicans transcription factor mutants using Galleria mellonella and mouse infection models.

Amorim-Vaz S, Delarze E, Ischer F, Sanglard D, Coste AT.

Front Microbiol. 2015 May 5;6:367. doi: 10.3389/fmicb.2015.00367. eCollection 2015.

17.

Distinct roles of Candida albicans drug resistance transcription factors TAC1, MRR1, and UPC2 in virulence.

Lohberger A, Coste AT, Sanglard D.

Eukaryot Cell. 2014 Jan;13(1):127-42. doi: 10.1128/EC.00245-13. Epub 2013 Nov 15.

18.

Identification and functional characterization of Rca1, a transcription factor involved in both antifungal susceptibility and host response in Candida albicans.

Vandeputte P, Pradervand S, Ischer F, Coste AT, Ferrari S, Harshman K, Sanglard D.

Eukaryot Cell. 2012 Jul;11(7):916-31. doi: 10.1128/EC.00134-12. Epub 2012 May 11.

19.

Azole resistance by loss of function of the sterol Δ⁵,⁶-desaturase gene (ERG3) in Candida albicans does not necessarily decrease virulence.

Vale-Silva LA, Coste AT, Ischer F, Parker JE, Kelly SL, Pinto E, Sanglard D.

Antimicrob Agents Chemother. 2012 Apr;56(4):1960-8. doi: 10.1128/AAC.05720-11. Epub 2012 Jan 17.

20.

Antifungal resistance and new strategies to control fungal infections.

Vandeputte P, Ferrari S, Coste AT.

Int J Microbiol. 2012;2012:713687. doi: 10.1155/2012/713687. Epub 2011 Dec 1.

21.

In vivo systematic analysis of Candida albicans Zn2-Cys6 transcription factors mutants for mice organ colonization.

Vandeputte P, Ischer F, Sanglard D, Coste AT.

PLoS One. 2011;6(10):e26962. doi: 10.1371/journal.pone.0026962. Epub 2011 Oct 31.

22.

Doxorubicin induces drug efflux pumps in Candida albicans.

Kofla G, Turner V, Schulz B, Storch U, Froelich D, Rognon B, Coste AT, Sanglard D, Ruhnke M.

Med Mycol. 2011 Feb;49(2):132-42. doi: 10.3109/13693786.2010.512022. Epub 2010 Sep 6.

PMID:
20818920
23.

Functional analysis of cis- and trans-acting elements of the Candida albicans CDR2 promoter with a novel promoter reporter system.

Coste AT, Crittin J, Bauser C, Rohde B, Sanglard D.

Eukaryot Cell. 2009 Aug;8(8):1250-67. doi: 10.1128/EC.00069-09. Epub 2009 Jun 26.

24.

Divergent functions of three Candida albicans zinc-cluster transcription factors (CTA4, ASG1 and CTF1) complementing pleiotropic drug resistance in Saccharomyces cerevisiae.

Coste AT, Ramsdale M, Ischer F, Sanglard D.

Microbiology. 2008 May;154(Pt 5):1491-501. doi: 10.1099/mic.0.2007/016063-0.

PMID:
18451058
25.
26.

The CRH family coding for cell wall glycosylphosphatidylinositol proteins with a predicted transglycosidase domain affects cell wall organization and virulence of Candida albicans.

Pardini G, De Groot PW, Coste AT, Karababa M, Klis FM, de Koster CG, Sanglard D.

J Biol Chem. 2006 Dec 29;281(52):40399-411. Epub 2006 Oct 30.

27.

CRZ1, a target of the calcineurin pathway in Candida albicans.

Karababa M, Valentino E, Pardini G, Coste AT, Bille J, Sanglard D.

Mol Microbiol. 2006 Mar;59(5):1429-51.

28.
29.

Supplemental Content

Loading ...
Support Center